ÃÑ 619ÆäÀÌÁö
619ÆäÀÌÁö º»¹®½ÃÀÛ
holders will be advised directly prior to permit amendment.
The following species have been removed from the BICON case ¡®Bulbs that are hosts of
Xylella fastidiosa for growth in open quarantine¡¯following a review of species listings in
BICON:
Nothoscordum neriniflorum
Nothoscordum neriniflorum var. albiflorum
No other changes have been made to import conditions for 'Bulbs that are hosts of
Xylella fastidiosa for growth in open quarantine'.
No import permits are affected by this change.
Background:
The species listed above are listed in the BICON case ¡®Plant species requiring further
assessment¡¯ and are currently not permitted entry because insufficient information is
available on their risk status.
Humantherapeuticsandmedicines
The import conditions for clinical trial medicines has been reviewed.
The importer declaration has been changed:
The statements required to be made by the importer have been condensed to address the
specific import requirement.
Clarification that the importer declaration does not have to be consignment specific,
however it must clearly identify the goods being imported
Goods imported primarily for use in clinical trials may also be used under the Therapeutic
Goods Administration Special Access Scheme.
- 619 -
The following species have been removed from the BICON case ¡®Bulbs that are hosts of
Xylella fastidiosa for growth in open quarantine¡¯following a review of species listings in
BICON:
Nothoscordum neriniflorum
Nothoscordum neriniflorum var. albiflorum
No other changes have been made to import conditions for 'Bulbs that are hosts of
Xylella fastidiosa for growth in open quarantine'.
No import permits are affected by this change.
Background:
The species listed above are listed in the BICON case ¡®Plant species requiring further
assessment¡¯ and are currently not permitted entry because insufficient information is
available on their risk status.
Humantherapeuticsandmedicines
The import conditions for clinical trial medicines has been reviewed.
The importer declaration has been changed:
The statements required to be made by the importer have been condensed to address the
specific import requirement.
Clarification that the importer declaration does not have to be consignment specific,
however it must clearly identify the goods being imported
Goods imported primarily for use in clinical trials may also be used under the Therapeutic
Goods Administration Special Access Scheme.
- 619 -
619ÆäÀÌÁö º»¹®³¡
¸Þ´º
ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.